Table 3 Second malignancies in study group

Lung carcinoma

8 (6 %)

Gastric carcinoma

3 (2 %)

Colon carcinoma

2 (2 %)

Lymphoma

2 (2 %)

Lip, skin carcinoma

2 (2 %)

Hypopharynx

2 (2 %)

Soft tissue carcinosarcoma^b

1 (1 %)

Renal cell carcinoma

1 (1 %)

Heamatologic malignancy

1 (1 %)

Adrenal tumor

1 (2 %)

Ovarian carcinoma

1 (1 %)